Drug information for DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
5GM/100ML;900MG/100ML
Prescription
AP
DEXTROSE
;
SODIUM CHLORIDE
Solutions
HOSPIRA
17585
INJECTABLE; INJECTION
5GM/100ML;900MG/100ML
Discontinued
DEXTROSE
;
SODIUM CHLORIDE
Solutions
B BRAUN
18026
INJECTABLE; INJECTION
5GM/100ML;900MG/100ML
Discontinued
DEXTROSE
;
SODIUM CHLORIDE
Solutions
MILES
18500
INJECTABLE; INJECTION
5GM/100ML;900MG/100ML
Discontinued
DEXTROSE
;
SODIUM CHLORIDE
Solutions
ABBOTT
19483
INJECTABLE; INJECTION
5GM/100ML;900MG/100ML
Prescription
AP
DEXTROSE
;
SODIUM CHLORIDE
Solutions
B BRAUN
19631
2004-09-29 Letter
2004-09-29 Label
Drug Adverse Effects information for DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Role code
Indications
Reaction
# Reports
C
DEEP VEIN THROMBOSIS
ANAEMIA
1
C
DEEP VEIN THROMBOSIS
ASTHENIA
1
C
DEEP VEIN THROMBOSIS
BLOOD LACTIC ACID INCREASED
1
C
DEEP VEIN THROMBOSIS
CARDIOVASCULAR DISORDER
1
C
DEEP VEIN THROMBOSIS
CHILLS
1
C
DEEP VEIN THROMBOSIS
COAGULOPATHY
1
C
DEEP VEIN THROMBOSIS
COMPARTMENT SYNDROME
1
C
DEEP VEIN THROMBOSIS
DEEP VEIN THROMBOSIS
1
C
DEEP VEIN THROMBOSIS
DYSPNOEA
1
C
DEEP VEIN THROMBOSIS
HAEMORRHAGE
1
C
DEEP VEIN THROMBOSIS
HYPERBILIRUBINAEMIA
1
C
DEEP VEIN THROMBOSIS
HYPERGLYCAEMIA
1
C
DEEP VEIN THROMBOSIS
HYPERHIDROSIS
1
C
DEEP VEIN THROMBOSIS
HYPOTENSION
1
C
DEEP VEIN THROMBOSIS
LEUKOCYTOSIS
1
C
DEEP VEIN THROMBOSIS
ORGAN FAILURE
1
C
DEEP VEIN THROMBOSIS
PLATELET COUNT DECREASED
1
C
DEEP VEIN THROMBOSIS
PYREXIA
1
C
DEEP VEIN THROMBOSIS
RENAL FAILURE
1
C
DEEP VEIN THROMBOSIS
SEPSIS
1
C
DEEP VEIN THROMBOSIS
SWELLING
1
C
DEEP VEIN THROMBOSIS
TACHYCARDIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ANAEMIA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
ASTHENIA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD LACTIC ACID INCREASED
22
C
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOVASCULAR DISORDER
22
C
PRODUCT USED FOR UNKNOWN INDICATION
CHILLS
22
C
PRODUCT USED FOR UNKNOWN INDICATION
COAGULOPATHY
22
C
PRODUCT USED FOR UNKNOWN INDICATION
COMPARTMENT SYNDROME
22
C
PRODUCT USED FOR UNKNOWN INDICATION
DEEP VEIN THROMBOSIS
22
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMORRHAGE
22
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERBILIRUBINAEMIA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERGLYCAEMIA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERHIDROSIS
22
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTENSION
22
C
PRODUCT USED FOR UNKNOWN INDICATION
LEUKOCYTOSIS
22
C
PRODUCT USED FOR UNKNOWN INDICATION
ORGAN FAILURE
22
C
PRODUCT USED FOR UNKNOWN INDICATION
PLATELET COUNT DECREASED
22
C
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
22
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE
22
C
PRODUCT USED FOR UNKNOWN INDICATION
SEPSIS
22
C
PRODUCT USED FOR UNKNOWN INDICATION
SWELLING
22
C
PRODUCT USED FOR UNKNOWN INDICATION
TACHYCARDIA
22
C
TUMOUR EXCISION
ANAEMIA
1
C
TUMOUR EXCISION
ASTHENIA
1
C
TUMOUR EXCISION
BLOOD LACTIC ACID INCREASED
1
C
TUMOUR EXCISION
CARDIOVASCULAR DISORDER
1
C
TUMOUR EXCISION
CHILLS
1
C
TUMOUR EXCISION
COAGULOPATHY
1
C
TUMOUR EXCISION
COMPARTMENT SYNDROME
1
C
TUMOUR EXCISION
DEEP VEIN THROMBOSIS
1
C
TUMOUR EXCISION
DYSPNOEA
1
C
TUMOUR EXCISION
HAEMORRHAGE
1
C
TUMOUR EXCISION
HYPERBILIRUBINAEMIA
1
C
TUMOUR EXCISION
HYPERGLYCAEMIA
1
C
TUMOUR EXCISION
HYPERHIDROSIS
1
C
TUMOUR EXCISION
HYPOTENSION
1
C
TUMOUR EXCISION
LEUKOCYTOSIS
1
C
TUMOUR EXCISION
ORGAN FAILURE
1
C
TUMOUR EXCISION
PLATELET COUNT DECREASED
1
C
TUMOUR EXCISION
PYREXIA
1
C
TUMOUR EXCISION
RENAL FAILURE
1
C
TUMOUR EXCISION
SEPSIS
1
C
TUMOUR EXCISION
SWELLING
1
C
TUMOUR EXCISION
TACHYCARDIA
1
Ads by Google